New Jersey State Board of Dentistry

The Division of Consumer Affairs (Division) is warning all licensed professionals about individuals impersonating New Jersey Division of Consumer Affairs (DCA) investigators, Drug Enforcement Administration (DEA) agents, DEA investigators, New Jersey Drug Control Unit investigators, Federal Bureau of Investigation (FBI) investigators, and other law enforcement personnel, as part of an extortion scheme.

The impersonators are contacting licensees by telephone or letter, stating that they are the subject of an investigation. The callers are demanding money to clear up the matter, or threatening to revoke the individual's license. Please be advised that the Division of Consumer Affairs will not contact licensees by telephone to discuss investigations or demand money.

Anyone receiving a telephone call from a person purporting to be any of the above mentioned individuals seeking money, should refuse the demand. We encourage you to report the call to the Federal Trade Commission (FTC) at ReportFraud.ftc.gov. You may also report the call to the Division at AskConsumerAffairs@lps.state.nj.us.

On January 7, 2013 the Board of Pharmacy and Drug Control Unit adopted rules to allow prescribers to issue Schedule II controlled substances prescriptions electronically in accordance with federal requirements. New Jersey practitioners and pharmacies can utilize EPCS for all patient prescriptions.
View EPCS Information (10/5/2015)

In July, Senate Bill 1998 was signed into law (P.L.2015, c.74) which substantially revises the scope and expands the capabilities of the New Jersey Prescription Monitoring Program (NJPMP). The Division of Consumer Affairs is tasked with implementing the new law, which takes effect on November 1, 2015.
View Notice (9/2015)